DekaBank Deutsche Girozentrale
EVGN icon

DekaBank Deutsche Girozentrale’s Evogene EVGN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-370
Closed -$31K – 1088
2015
Q3 		$31K Buy
+370
New +$32.2K ﹤0.01% 1067

Other funds holding EVGN

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MTWSIF
Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

DekaBank Deutsche Girozentrale's EVGN Position: Q4 2015 in Review

DekaBank Deutsche Girozentrale sold out of Evogene (EVGN) in Q4 2015, closing a stake of 370 shares — an estimated $31K sold.

DekaBank Deutsche Girozentrale first reported a position in EVGN in Q3 2015 and held it in 1 quarter. The position peaked at $31K in Q3 2015. 19 funds tracked by Wall St. Rank hold EVGN as of Q4 2015.

  • DekaBank Deutsche Girozentrale reported no remaining Evogene position as of Q4 2015 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 370 Evogene shares in Q4 2015, an estimated $31K.
  • DekaBank Deutsche Girozentrale first reported a position in Evogene in Q3 2015 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's Evogene position peaked at $31K in Q3 2015.
  • 19 funds tracked by Wall St. Rank held Evogene as of Q4 2015.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2015, filed 25 Jan 2016.